POPTASSIUM/MAGNESIUM CITRATE IN THIAZIDE TREATED NEPHROLITHIASIS

噻嗪类药物治疗肾结石中的柠檬酸钾/镁

• 批准号: 3742834
• 负责人: CHARLES YC PAK
• 金额: --
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3742834
• 关键词: citrates; combination therapy; disease /disorder prevention /control; drug screening /evaluation; human subject; human therapy evaluation; magnesium; magnesium deficiency; medical complication; nephrolithiasis; potassium; potassium deficiency; thiazide

The goal of this project is to show that Potassium-Magnesium citrate (a new compound developed at Dallas) is superior to Magnesium Citrate or Potassium Citrate in the control of kidney stone formation and in preventing potassium-magnesium depletion.

本项目的目标是证明柠檬酸钾镁（a 达拉斯开发的新化合物）上级柠檬酸镁或 柠檬酸钾在控制肾结石形成和治疗肾结石中的作用 防止钾镁耗尽。